skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD

Journal Article · · Nature Communications

Pyrazinamide has been a mainstay in the multidrug regimens used to treat tuberculosis. It is active against the persistent, non-replicating mycobacteria responsible for the protracted therapy required to cure tuberculosis. Pyrazinamide is a pro-drug that is converted into pyrazinoic acid (POA) by pyrazinamidase, however, the exact target of the drug has been difficult to determine. Here we show the enzyme PanD binds POA in its active site in a manner consistent with competitive inhibition. The active site is not directly accessible to the inhibitor, suggesting the protein must undergo a conformational change to bind the inhibitor. This is consistent with the slow binding kinetics we determined for POA. Drug-resistant mutations cluster near loops that lay on top of the active site. These resistant mutants show reduced affinity and residence time of POA consistent with a model where resistance occurs by destabilizing the closed conformation of the active site.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE; National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH)
OSTI ID:
1603168
Journal Information:
Nature Communications, Vol. 11, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 25 works
Citation information provided by
Web of Science

References (28)

Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide journal January 2002
Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. journal July 1988
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus journal June 1996
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD journal October 2017
Extra Precision Glide:  Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes journal October 2006
Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I journal April 2002
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1 journal March 2017
HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes journal July 2006
The oligomeric structures of plant cryptochromes journal May 2020
Crystal Structure of the Schiff Base Intermediate Prior to Decarboxylation in the Catalytic Cycle of Aspartate α-Decarboxylase journal June 2004
TrkA undergoes a tetramer-to-dimer conversion to open TrkH which enables changes in membrane potential journal January 2020
Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis journal September 2015
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis journal August 2011
Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid journal September 2003
Pantothenate and Pantetheine Antagonize the Antitubercular Activity of Pyrazinamide journal September 2014
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis journal September 2000
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization journal September 2009
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis journal January 2014
The intrinsic structure of poly(A) RNA determines the specificity of Pan2 and Caf1 deadenylases journal May 2019
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA journal July 2017
Validation of Drug-Like Inhibitors against Mycobacterium Tuberculosis L-Aspartate α-Decarboxylase Using Nuclear Magnetic Resonance (1H NMR) journal September 2012
A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis journal September 2002
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis journal January 2013
Polder maps: improving OMIT maps by excluding bulk solvent journal February 2017
Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide journal March 2019
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery journal October 2011
Phaser crystallographic software journal July 2007
Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD journal August 2002